IONIS PHARMACEUTICALS INC (IONS) insider trading

By person

28 insiders · 644 transactions

10.0×

Brett P. Monia holds 10.0 times base salary in stock. $10.57M of shares against $1.05M in salary for 2025.

Salary from the company's own proxy. The shares are what Brett P. Monia last reported holding, valued at $43.54, the price Common Stock was last bought or sold at on the open market here, on 16 Oct 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Brett P Monia

Chief Executive Officer

—

$60.06M (60) scheduled

−$60.06M

242,760

0.1461%

$10.57M

+3,096%

Stanley T Crooke

Exec Chairman of the Board

—

$44.34M (107) scheduled

−$44.34M

1,202,384

0.7235%

$52.35M

−14.1%

C Frank Bennett

EVP, Chief Scientific Officer

—

$30.87M (45) scheduled

−$30.87M

60,128

0.0362%

$2.62M

+281.3%

Patrick R. O'Neil

EVP CLO & General Counsel

—

$30.65M (81) scheduled

−$30.65M

59,205

0.0356%

$2.58M

+523.7%

Elizabeth L Hougen

EVP, Finance & CFO

—

$27.53M (36) scheduled

−$27.53M

82,660

0.0497%

$3.60M

+1,170%

Richard S Geary

EVP, Chief Development Officer

—

$23.43M (43) scheduled

−$23.43M

59,657

0.0359%

$2.60M

+603.3%

B Lynne Parshall

Director

—

$17.35M (33) scheduled

−$17.35M

51,344

0.0309%

$2.24M

+207.6%

Joseph Klein III

Director

—

$12.81M (50) scheduled

−$12.81M

11,014

0.0066%

$479.54K

+43.8%

Eric Swayze

EVP Research

—

$11.07M (32) scheduled

−$11.07M

22,467

0.0135%

$978.19K

+2,034%

Joseph H Wender

Director

—

$10.14M (17) scheduled

−$10.14M

52,035

0.0313%

$2.27M

−15.8%

Shannon L. Devers

EVP, Chief Human Resources Ofc

—

$9.05M (17) scheduled

−$9.05M

17,811

0.0107%

$775.47K

+125.2%

Joseph Loscalzo

Director

—

$8.56M (7) scheduled

−$8.56M

36,330

0.0219%

$1.58M

+654.7%

Eugene Schneider

EVP, Chf Clinical Develop Ofcr

—

$7.94M (15) scheduled

−$7.94M

77,114

0.0464%

$3.36M

+192.0%

Joseph Baroldi

EVP, Chief Business Officer

—

$7.09M (25) scheduled

−$7.09M

49,578

0.0298%

$2.16M

+1,065%

Allene M. Diaz

Director

—

$5.39M (8) scheduled

−$5.39M

3,811

0.0023%

$165.93K

—

Spencer R Berthelsen

Director

—

$4.88M (9) scheduled

−$4.88M

161,233

0.0970%

$7.02M

+103.2%

Holly B. Kordasiewicz

EVP, Chief Development Officer

—

$4.81M (4) scheduled

−$4.81M

22,096

0.0133%

$962.04K

+42.7%

Brian Birchler

EVP, Corp and Development Ops

—

$4.04M (11) scheduled

−$4.04M

102,883

0.0619%

$4.48M

+45.6%

Kyle Jenne

EVP, Chf GL Pdt Str Ofcr

—

$3.42M (5) scheduled

−$3.42M

23,713

0.0143%

$1.03M

+1,092%

Frederick T Muto

Director

—

$3.37M (7) scheduled

−$3.37M

59,597

0.0359%

$2.59M

+713.6%

Joan E Herman

Director

—

$3.17M (2) scheduled

−$3.17M

51,306

0.0309%

$2.23M

—

Michael R Hayden

Director

$1.72M (5)

—

+$1.72M

78,298

0.0471%

$3.41M

+1,857%

Onaiza Cadoret-Manier

EVP, Chf GL Pdt Str & Oper Ofc

—

$687.39K (5)

−$687.39K

35,825

0.0216%

$1.56M

—

Breaux Castleman

Director

—

$600.00K (1) scheduled

−$600.00K

19,183

0.0115%

$835.21K

+110.6%

Sarah Boyce

Chief Business Officer

—

$176.67K (3)

−$176.67K

8,931

0.0054%

$388.85K

+317.7%

Peter N Reikes

Director

—

14,222

0.0086%

$619.21K

—

Michael J. Yang

Director

—

7,940

0.0048%

$345.70K

—

Damien McDevitt

Chief Business Officer

—

2,573

0.0015%

$112.03K

—

IONIS PHARMACEUTICALS INC

What the insiders did Net selling

By person